IRIS
LOZZI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.489
EU - Europa 7.284
AS - Asia 3.924
SA - Sud America 720
AF - Africa 200
Continente sconosciuto - Info sul continente non disponibili 152
OC - Oceania 19
Totale 29.788
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.314
CN - Cina 1.634
GB - Regno Unito 1.576
RU - Federazione Russa 1.328
SG - Singapore 1.058
IE - Irlanda 921
IT - Italia 798
SE - Svezia 636
UA - Ucraina 633
BR - Brasile 569
DE - Germania 504
FR - Francia 407
VN - Vietnam 337
HK - Hong Kong 282
KR - Corea 204
FI - Finlandia 203
ZA - Sudafrica 109
IN - India 100
CA - Canada 78
ES - Italia 70
BD - Bangladesh 52
AR - Argentina 51
BE - Belgio 35
NG - Nigeria 33
PL - Polonia 33
NL - Olanda 32
MX - Messico 31
JP - Giappone 29
TR - Turchia 27
EC - Ecuador 22
PK - Pakistan 22
VE - Venezuela 22
CO - Colombia 20
IQ - Iraq 20
RO - Romania 20
CZ - Repubblica Ceca 18
AT - Austria 16
AU - Australia 16
IR - Iran 15
PH - Filippine 15
CI - Costa d'Avorio 14
ID - Indonesia 14
JO - Giordania 14
IL - Israele 12
JM - Giamaica 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CL - Cile 9
EU - Europa 9
KE - Kenya 9
MY - Malesia 9
NP - Nepal 9
CR - Costa Rica 8
EG - Egitto 8
MA - Marocco 8
SA - Arabia Saudita 8
TN - Tunisia 8
LB - Libano 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
DZ - Algeria 6
EE - Estonia 6
KZ - Kazakistan 6
LT - Lituania 6
PE - Perù 6
RS - Serbia 6
SV - El Salvador 6
GR - Grecia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GD - Grenada 4
GE - Georgia 4
GP - Guadalupe 4
GT - Guatemala 4
NO - Norvegia 4
BB - Barbados 3
BO - Bolivia 3
CW - ???statistics.table.value.countryCode.CW??? 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
Totale 29.632
Salva come PNG Salva come JPEG
Città #
Dallas 8.011
Southend 1.381
Ashburn 1.041
Dublin 914
Fairfield 812
Menlo Park 620
Singapore 594
Chandler 587
Jacksonville 496
Woodbridge 440
Santa Clara 399
San Jose 392
Moscow 357
Wilmington 350
Beijing 348
Seattle 348
Houston 341
Ann Arbor 291
Cambridge 285
Hong Kong 277
Hefei 246
Milan 224
Seoul 203
Siena 197
Nanjing 180
Council Bluffs 172
Princeton 169
Los Angeles 119
New York 111
The Dalles 111
Ho Chi Minh City 108
Johannesburg 105
Rome 100
Helsinki 87
Shanghai 84
Fremont 83
Boardman 82
Lauterbourg 80
Hanoi 73
Munich 73
San Mateo 69
Nanchang 67
Buffalo 63
São Paulo 63
Málaga 50
San Diego 50
Dong Ket 45
Dearborn 43
Shenyang 39
Orem 37
Chicago 34
Abuja 33
Brussels 32
Changsha 31
Tianjin 30
Hebei 29
Redwood City 29
Toronto 29
Turku 28
London 27
Figino 26
Warsaw 26
San Francisco 25
Columbus 24
Jiaxing 24
Brooklyn 23
Bengaluru 22
Chennai 22
Frankfurt am Main 22
Kunming 22
Zhengzhou 21
Amsterdam 20
Florence 20
Jinan 20
Tokyo 20
Washington 20
Boston 17
Brasília 16
Atlanta 15
Belo Horizonte 15
Guangzhou 15
Rio de Janeiro 15
Turin 15
University Park 15
Abidjan 14
Montreal 14
Phoenix 14
Amman 13
Kansas City 13
Lancaster 13
Redondo Beach 13
Brno 12
Denver 12
Ningbo 12
Timisoara 12
Dhaka 11
Paris 11
Stockholm 11
Hangzhou 10
Hải Dương 10
Totale 22.394
Salva come PNG Salva come JPEG
Nome #
1 H‐ and natural abundance 15 N‐nmr studies of a derivative of a rabies glycoprotein fragment 7.503
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 406
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 389
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 371
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 354
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 348
A model of the rabies virus glycoprotein active site 335
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 334
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 331
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 320
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 312
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 304
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 287
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 281
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 281
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 277
Tumor imaging with tetrabranched neurotensin 276
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate camcer metastates, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2 272
Bioactive peptides from libraries 268
CD and NMR structural characterization of ceratotoxins, natural peptides with antimicrobial activity 268
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 267
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 264
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 263
Toxin-related antibodies with antimicrobial and antiviral activity 262
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 262
Branched Neurotensin For Tumor Targeting 261
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 256
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 252
Branched peptides as targeting agents for tumor imaging and therapy 251
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 250
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 247
Dynein heavy chain related polypeptides in growing pollen tube of Nicotiana tabacum 246
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 244
Highly fluorescent protein labeling using dendritic peptide derivatives 241
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 240
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 236
Synthetic peptides in the form of dendrimers become resistant to protease activity 233
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 232
Antigenicity of synthetic peptides derived from C100 protein of hepatitis C virus 232
The antimicrobial peptide M33. An example of drug development 231
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 228
Tumor selective targeting by branched peptides 228
Single step purification of a synthetic peptide fragment of neurofilaments by preparative high performance liquid-chromatography 227
Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins 226
Branched neurotensin for tumor targeting 224
Surface Plasmon Resonance analysis of HIV-1 gp 120 binding to muscle nicotinic receptors 223
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 222
Interaction of Angiotensin II with the C-terminal 300-320 fragment of the rat Angiotensin II Receptor AT1a monitored by NMR 219
Micro-determination of amino acid composition of proteins electroblotted onto polyvinylidene difluoride membranes 216
Molecular basis of branched peptides resistance to enzyme proteolysis 215
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 214
Binding of HIV-1 gp120 to the nicotinic receptor 214
The 208-222 region of the peplomer glycoprotein putative binding site of the rabiesvirus with the nicotinic acetylcholine receptor 213
High molecular weight polypeptides related to dynein heavy chains in Nicotiana tabacum pollen tubes 212
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 211
Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides 209
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 208
Synthetic peptides of rubella E1 glycoprotein for serological assays 207
Antigenic recognition of pertussis and cholera toxin by the same antipeptide antibodies 204
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances 204
Epitopes identification by limited proteolysis 202
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies 197
Structure and antigenic activity of rubella E1 glycoprotein synthetic peptides 194
Synthetic antidotes against snake neurotoxins 192
SNARE motif and neurotoxins 191
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 189
Selection of catalytically active biotin ligase and trypsin mutants by phage display 189
Recognition of CMV pp65 protein antigen by human CD4 T cell lines induced with an immunodominant peptide pool 188
Branched neurotensin peptides for tumor targeting 188
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 188
Tumor imaging with tetrabranched neurotensin 187
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution 187
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies 185
Dendrimeric peptides for tumor targeting 183
Toxin-related antibodies with antimicrobial and antiviral activity 183
The antimicrobial peptide M33. An example of drug development 182
The 208-222 Region of the peplomer Glycoprotein as a putative binding site of rabies virus with the nicotinic acetylcholine receptor 181
Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85 179
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 173
Polipeptidi correlati alle catene pesanti delle dineine in tubetti pollinici di Nicotiana tabacum 173
Synthetic inhibitors of anthrax lethal toxin 172
Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66 172
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 171
A strategy for isolation af catalytic activities from repertoires of enzymes displayed on phage 166
Synthesis and purification of site-specific peptide conjugated to bovine pancreatic trypsin inhibitor 166
Natural analogue peptides of an HIV-1 GP-120 T-helper epitope antagonize response of GP-120 specific human CD4 T-cell clones 165
NMR structure of alpha-bungarotoxin free and bound to a mimotope of the nicotinic acetylcholine receptor 165
Histidyl tags and structural stabilization of linear peptides 162
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 162
Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell binding site 161
New Developments in Heterocyclic Silyl Enol Ether Chemistry: Synthesis and Lewis Acid Mediated Reactions with Carbon Electrophiles of 2,5-bis(trimethylsiloxy)thiophene and 1-Methyl-2,5-bis(trimethylsiloxy)pyrrole 155
On the structural stability of a small bioactive peptide of potential use in biotechnology 152
Synthetic peptides in the form of dendrimers can become resistant to protease activity 150
Resolution of Conformational Equilibria In Linear Peptides By Circular-dichroism In Cryogenic Solvents 150
Role of manganese in MG-63 osteosarcoma cell attachment to fibrinogen and von Willabrand factor 146
Recognition of human T-leukaemia virus (HTLV-1) envelope by human CD4+ - cell lines from HTLV-1 seronegative individuals: Specificity and clonal heterogeneity 146
Strong synthetic inhibitors of anthrax lethal toxin 146
Structurally driven selection of human hepatitis C virus mimotopes. 145
NMR studies of the interaction of alpha-bungarotoxin with a mimotope of the nicotinic acetylcholine receptor 138
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 131
Totale 29.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022759 0 0 0 0 61 30 51 61 44 127 117 268
2022/20232.024 124 210 248 296 206 398 27 171 184 71 72 17
2023/20241.351 37 51 143 70 50 393 474 16 3 15 10 89
2024/20252.555 65 142 272 137 294 132 70 132 203 86 285 737
2025/202613.237 491 2.672 5.947 831 1.184 243 582 204 230 288 100 465
2026/20271.543 214 165 618 504 42 0 0 0 0 0 0 0
Totale 29.788